Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E

Fig. 1

Glycolytic metabolism is highly diverted into the serine and glycine synthesis flux in PANC-1 cells. a and b Glucose consumption rates and pyruvate yield rates in different breast cancer, melanoma and pancreatic cancer cells in 24 h. c Schematic of glucose glycolytic metabolism divided into serine and glycine at 3-P-D-glycerate through PHGDH and SHMT1, and alanine at pyruvate through ALT respectively. d, e andf Carbon-unlabeled and labeled contents of alanine, serine and glycine in HMEC, MDA-MB-231, PANC-1 and SW1990 cells. g qRT-PCR and western blot analysis of the PHGDH and SHMT1 mRNA and protein levels in HMEC and PANC-1 cells. h Immunohistochemical analysis of PHGDH and SHMT1 expression levels in 24 pancreatic adenocarcinomas and 4 normal adjacent tissues. 4 representative cores with different malignancies are shown in the figure. Data are representative of at least three independent experiments. p value: Student’s t-test; ***p < 0.001. Columns: mean; bars: SD

Back to article page